Top

Published in:

01-06-2010 | Original Research

Parental Attitudes, Beliefs, and Perceptions about Genetic Testing for FAP and Colorectal Cancer Surveillance in Minors

Authors: Fallon R. Levine, James E. Coxworth, David A. Stevenson, Thérèse Tuohy, Randall W. Burt, Anita Y. Kinney

Published in: Journal of Genetic Counseling | Issue 3/2010

Abstract

Familial adenomatous polyposis (FAP) is the second most common hereditary colorectal cancer syndrome and confers a nearly 100% lifetime risk of developing colorectal cancer. Understanding factors that facilitate and inhibit genetic testing and cancer surveillance in children who are members of families affected by FAP will better equip clinicians to clarify misunderstandings and facilitate appropriate care. The aims of this study were to examine parental attitudes and beliefs regarding endoscopic surveillance and genetic testing in minors at risk for developing FAP. This cross-sectional study includes analyses of qualitative and quantitative interview data collected from parents of children with or at risk for FAP. This report includes data from 28 parents with a total of 51 biological children between 10–17 years of age. The parents had a clinical and/or genetic diagnosis of FAP. Most commonly reported facilitators included provider recommendation (surveillance) and personalized medical management (genetic testing). Most commonly reported barriers included lack of provider recommendation (surveillance) and cost (genetic testing).

Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50(2), 179–211.CrossRef

Al-Sukhni, W., Aronson, M., & Gallinger, S. (2008). Hereditary colorectal cancer syndromes: familial adenomatous Polyposis and Lynch syndrome. Surgical Clinics of North America, 88, 819–844.CrossRef

American Academy of Pediatrics Committee on Bioethics. (2001). Ethical issues with genetic testing in pediatrics. Pediatrics, 107(6), 1451–1455.CrossRef

American Society of Clinical Oncology. (2003). American society of clinical oncology policy statement update: genetic testing for cancer susceptibility. Journal of Clinical Oncology, 21(12), 2397–2406.CrossRef

American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. (1995). Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Journal of Human Genetics, 57(5), 1233–1241.

Augustyn, A. W., & Wallerstein, R. (2009). The role of pediatricians in families with a history of familial adenomatous polyposis. Clinical Pediatrics, 48(6), 623–626.PubMedCrossRef

Baty, B. J., Dudley, W. N., Musters, A., & Kinney, A. Y. (2006). Uncertainty in BRCA1 cancer susceptibility testing. American Journal of Medical Genetics Part C, 142C(4), 241–250.CrossRef

Bisgaard, M. L., Fenger, K., Bülow, S., Niebuhr, E., & Mohr, J. (1994). Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Human Mutation, 3(2), 121–125.PubMedCrossRef

Borry, P., Stultiëens, L., Nys, H., & Dierickx, K. (2007). Attitudes towards predictive genetic testing in minors for familial breast cancer: a systematic review. Oncology Hematology, 64(3), 173–181.

Burt, R. W., & Jasperson, K. W. (2008). APC- Associated Polyposis Conditions. GeneReviews, 1–31. Retrieved from https://doi.org/www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=fap.

Codori, A. M., Petersen, G. M., Miglioretti, D. L., Larkin, E. K., Bushey, M. T., Young, C., et al. (1999). Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiology Biomarkers and Prevention, 8(4 Pt2), 345–351.

Croner, R. S., Brueckl, W. M., Reingruber, B., Hohenberger, W., & Guenther, K. (2005). Age and manifestation related symptoms in familial adenomatous polyposis. BioMed Central Cancer, 5, 24.PubMedPubMedCentral

Douma, K. F., Aaronson, N. K., Vasen, H. F., & Bleiker, E. M. (2008). Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature. Psycho-Oncology, 17(8), 737–745.PubMedCrossRef

Duncan, R. E., Gillam, L., Savulescu, J., Williamson, R., Rogers, J. G., & Delatycki, M. B. (2008). “You’re one of us now”: young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). American Journal of Medical Genetics Part C, 148C(1), 47–55.CrossRef

Fanos, J. H. (1997). Developmental tasks of childhood and adolescence: implications for genetic testing. American Journal of Medical Genetics, 71(1), 22–28.PubMedCrossRef

Fearnhead, N. S., Britton, M. P., & Bodmer, W. F. (2001). The ABC of APC. Human Molecular Genetics, 10(7), 721–733.PubMedCrossRef

Gennarelli, M., Jandorf, L., Cromwell, C., Valdimarsdottir, H., Redd, W., & Itzkowitz, S. (2005). Barriers to colorectal cancer screening: inadequate knowledge by physicians. The Mount Sinai Journal of Medicine, 72(1), 36–44.PubMed

Gooding, H. C., Organista, K., Burack, J., & Biesecker, B. B. (2006). Genetic susceptibility testing from a stress and coping perspective. Social Science and Medicine, 62(8), 1880–1890.PubMedCrossRef

Gryfe, R. (2006). Clinical implications of our advancing knowledge of colorectal cancer genetics: inherited syndromes, prognosis, prevention, screening and therapeutics. Surgical Clinics of North America, 86(4), 787–817.CrossRef

Hall, M. A., & Rich, S. S. (2000). Patients’ fear of genetic discrimination by health insurers: the impact of legal protections. Genetics in Medicine, 2(4), 214–221.PubMedCrossRef

Janz, N. K., Lakhani, I., Vijan, S., Hawley, S. T., Chung, L. K., & Katz, S. J. (2007). Determinants of colorectal cancer screening use, attempts, and non-use. Preventive Medicine, 44(5), 452–458.PubMedCrossRef

Kastrinos, F., Stoffel, E. M., Balmaña, J., & Syngal, S. (2007). Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. American Journal of Gastroenterology, 102(6), 1284–1290.CrossRef

Khoury, M. J., Gwinn, M., Burke, W., Bowen, S., & Zimmern, R. (2007). Will genomics widen or help the schism between medicine and public health? American Journal of Preventive Medicine, 33(4), 310–317.PubMedCrossRef

Kinney, A. Y., Hicken, B., Simonsen, S. E., Venne, V., Lowstuter, K., Balzotti, J., et al. (2007). Colorectal cancer surveillance behaviors among members of typical and attenuated FAP families. American Journal of Gastroenterology, 102(1), 153–162.CrossRef

Kinzler, K. W., Nilbert, M. C., Su, L. K., Vogelstein, B., Bryan, T. M., Levy, D. B., et al. (1991). Identification of FAP locus genes from chromosome 5q21. Science, 253(5020), 661–665.PubMedCrossRef

Krippendorff, K. (1980). Content analysis: an introduction to its methodology. Beverly Hills: Sage.

Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorial data. Biometrics, 33(1), 159–174.PubMedCrossRef

Li, F. P., Garber, J. E., Friend, S. H., Strong, L. C., Patenaude, A. F., Juengst, E. T., et al. (1992). Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. Journal of the National Cancer Institute, 84(15), 1156–1160.PubMedCrossRef

Michie, S., McDonald, V., Bobrow, M., McKeown, C., & Marteau, T. (1996). Parents’ responses to predictive genetic testing in their children: report of a single case study. Journal of Medical Genetics, 33(4), 313–318.PubMedPubMedCentralCrossRef

Michie, S., Bobrow, M., & Marteau, T. M. (2001). Predictive genetic testing in children and adults: a study of emotional impact. Journal of Medical Genetics, 38(8), 519–526.PubMedPubMedCentralCrossRef

Michie, S., Smith, J. A., Senior, V., & Marteau, T. M. (2003). Understanding why negative genetic test results sometimes fail to reassure. American Journal of Medical Genetics A, 119A(3), 340–347.CrossRef

Miles, M. B., & Huberman, A. M. (1994). An expanded sourcebook: qualitative data analysis (2nd ed.). Thousand Oaks: Sage.

Mills, S. J., Chapman, P. D., Burn, J., & Gunn, A. (1997). Endoscopic screening and surgery for familial adenomatous polyposis: dangerous delays. British Journal of Surgery, 84(1), 74–77.CrossRef

National Comprehensive Cancer Network Colorectal Screening Panel (2003). Colorectal cancer screening clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 1(1), 72.CrossRef

National Comprehensive Cancer Network Colorectal Screening Panel (2009). Hereditary Syndromes: Familial Adenomatous Polyposis Syndromes. NCCN Practice Guidelines in Oncology: Colorectal Cancer Screening, v.1.2009. Retrieved from https://doi.org/www.nccn.org/professionals/physician_gls/PDF/colorectal_screening.pdf.

Nichols, C., Holt, C. L., Shipp, M., Eloubeide, M., Fouad, M. N., & Britt, K. (2009). Physician knowledge, perceptions of barriers, and patient colorectal cancer screening practices. American Journal of Medical Quality, 24(2), 116–122.PubMedCrossRef

Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., et al. (1991). Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253(5020), 665–669.PubMedCrossRef

Penziner, E., Williams, J. K., Erwin, C., Bombard, Y., Wallis, A., Beglinger, L. J., et al. (2008). Perceptions of discrimination among persons who have undergone predictive testing for Huntington’s disease. American Journal of Medical Genetics Part B, 147(3), 320–325.CrossRef

Petersen, G. M., Slack, J., & Nakamura, Y. (1991). Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology, 100(6), 1658–1664.PubMedCrossRef

Price, A. S. (2003). Primary and secondary prevention of colorectal cancer. Gastroenterology Nursing, 26(2), 73–81.PubMedCrossRef

Rawl, S. M., Menon, U., & Champion, V. (2002). Colorectal cancer screening: an overview of current trends. The Nursing Clinics of North America, 37(2), 225–245.PubMedCrossRef

Rosenstock, I. M., Strecher, V. J., & Becker, M. H. (1988). Social learning theory and the Health Belief Model. Health Education Quarterly, 15(2), 175–183.PubMedCrossRef

Sweet, K. M., Willis, S. K., Ashida, S., & Westman, J. A. (2003). Use of fear-appeal techniques in the design of tailored cancer risk communication messages: implications for healthcare providers. Journal of Clinical Oncology, 21(17), 3375–3376.PubMedCrossRef

Viera, A. J., & Garrett, J. M. (2005). Understanding interobserver agreement: the kappa statistic. Family Medicine, 37(5), 360–363.PubMed

Winawer, S., Fletcher, R., Rex, D., Bond, J., Burt, R., Ferrucci, J., et al. (2003). American Gastroenterological Association colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology, 124, 544–560.PubMedCrossRef

Title: Parental Attitudes, Beliefs, and Perceptions about Genetic Testing for FAP and Colorectal Cancer Surveillance in Minors
Authors: Fallon R. Levine
James E. Coxworth
David A. Stevenson
Thérèse Tuohy
Randall W. Burt
Anita Y. Kinney
Publication date: 01-06-2010
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 3/2010
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-010-9285-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Parental Attitudes, Beliefs, and Perceptions about Genetic Testing for FAP and Colorectal Cancer Surveillance in Minors

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2010

Commentary on “Life as a Pregnant Genetic Counselor”

Re-conceptualizing Risk in Genetic Counseling: Implications for Clinical Practice

Concerns of South Korean Patients and Family Members Affected with Genetic Conditions: A Content Analysis of Internet Website Messages

Parental Decisions Regarding a Prenatally Detected Fetal Chromosomal Abnormality and the Impact of Genetic Counseling: An Analysis of 38 Cases with Aneuploidy in Southeast Turkey

Publishing a Master’s Thesis: A Guide for Novice Authors

Interest and Beliefs About BRCA Genetic Counseling Among At-Risk Latinas in New York City